Sort
48,018 grants matching “immunotherapy”
Mechanisms of liver metastasis and associated resistance to immunotherapy
$438,730Benjamin Izar · Columbia University Health Sciences · R37 · FY2022 · CA
Immunoengineered nanotechnology for targeted expansion of regulatory T cells
$438,721Jamie Berta Spangler · Johns Hopkins University · R01 · FY2020 · EB
Advancing T cell Therapy for Ovarian Cancer
$438,669George Coukos · Fox Chase Cancer Center · P50 · FY2009 · CA
S100A4 mediated immune suppression in GBM
$438,652Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2023 · NS
S100A4 mediated immune suppression in GBM
$438,652Kyuson Yun · Methodist Hospital Research Institute · R01 · FY2022 · NS
INTERLEUKIN 2 IMMUNOTHERAPY FOR HCV INFECTION
$438,581Weill Medical College Of Cornell Univ · U01 · FY2001 · AI
Engineering Responsive Chemical Heterogeneity in Protein Vesicles for Simultaneous Delivery of Diverse Cargoes
$438,521Julie Champion · Georgia Tech Research Corporation · · FY2021 · MPS
Dual-pronged nano-drug delivery using plant virus-like particles.
$438,466Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2018 · CA
Crosslinking conjugates to localize and activate NK cells in glioblastoma
$438,452Benjamin W. Purow · University Of Virginia · R21 · FY2019 · NS
A universal multi-drug encapsulation and delivery system employing supramolecular nanogels that self-assemble via dynamic sulfone bonding
$438,411Evan Alexander Scott · Northwestern University · R01 · FY2022 · EB
A universal multi-drug encapsulation and delivery system employing supramolecular nanogels that self-assemble via dynamic sulfone bonding
$438,411Evan Alexander Scott · Northwestern University · R01 · FY2023 · EB
Inner City Asthma consortium 3 (ICAC3)
$438,405Daniel J Jackson · University Of Wisconsin-Madison · UM1 · FY2020 · AI
Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanoma
$438,385Christopher Austin Klebanoff · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Chemotherapy plus vaccine for metastatic breast cancer
$438,356Johns Hopkins University · R01 · FY2005 · CA
Microenvironmental Influences in Cancer
$438,353Jin Chen · Vanderbilt University · T32 · FY2021 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$438,296Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Clinical implementation of single cell tumor transcriptome analysis
$438,255Aviv Regev · Broad Institute, Inc. · R33 · FY2017 · CA
Evaluating unique aspects of quiescent ovarian cancer cell biology for therapeutic targets
$438,083Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2023 · CA
Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy
$438,076Guillermo N Armaiz-Pena · Ponce School Of Medicine · R21 · FY2020 · CA
Resource for Nonhuman Primate Immune Reagents
$437,988Francois J Villinger · University Of Louisiana At Lafayette · R24 · FY2022 · OD
Potentiating Anti-WT1 responses by Targeting Peptide/MHC Complexes with T
$437,922David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Radiotherapy as Immunotherapy of Tumors
$437,914Samuel Strober · Stanford University · R01 · FY2016 · CA
Radiotherapy as Immunotherapy of Tumors
$437,914Samuel Strober · Stanford University · R01 · FY2015 · CA
Radiotherapy as Immunotherapy of Tumors
$437,914Samuel Strober · Stanford University · R01 · FY2012 · CA
MEDICINE ENHANCED IMMUNOTHERAPY AND TARGETED THERAPY FOR NON SMALL CELL LUNG CANCER
$437,906Brigham & Womens Hospital Inc · · FY2025 · Defense Health Agency